Current Assets
Short- term Investments
Revolution Medicines, Inc. Short- term Investments decreased by 10.6% to $1.47B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 17.1%, from $1.77B to $1.47B. Over 5 years (FY 2020 to FY 2025), Short- term Investments shows an upward trend with a 37.3% CAGR.
Analysis
StatementBalance Sheet Statement
SectionCurrent Assets
First reportedQ4 2019
Last reportedQ1 2026May 6, 2026
Metric ID:
current_assets_marketable_securities_currentHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $450.72M | $479.50M | $468.56M | $421.09M | $355.65M | $476.07M | $483.53M | $482.58M | $529.16M | $454.80M | $1.16B | $1.42B | $1.32B | $1.35B | $1.75B | $1.77B | $1.73B | $1.71B | $1.64B | $1.47B |
| QoQ Change | — | +6.4% | -2.3% | -10.1% | -15.5% | +33.9% | +1.6% | -0.2% | +9.7% | -14.1% | +154.4% | +22.3% | -7.1% | +2.5% | +29.5% | +1.3% | -1.9% | -1.2% | -4.2% | -10.6% |
| YoY Change | — | — | — | — | -21.1% | -0.7% | +3.2% | +14.6% | +48.8% | -4.5% | +139.2% | +193.2% | +148.5% | +196.4% | +51.0% | +25.0% | +31.9% | +27.1% | -6.0% | -17.1% |
Range$355.65M – $1.77B
CAGR+28.2%
Avg YoY Growth+51.9%
Median YoY Growth+26.1%
Current Streak4 quarters decline
Short- term Investments at Other Companies
Frequently Asked Questions
- What is Revolution Medicines, Inc.'s short- term investments?
- Revolution Medicines, Inc. (RVMD) reported short- term investments of $1.47B in Q1 2026.
- How has Revolution Medicines, Inc.'s short- term investments changed year-over-year?
- Revolution Medicines, Inc.'s short- term investments decreased by 17.1% year-over-year, from $1.77B to $1.47B.
- What is the long-term trend for Revolution Medicines, Inc.'s short- term investments?
- Over 5 years (2020 to 2025), Revolution Medicines, Inc.'s short- term investments has grown at a 37.3% compound annual growth rate (CAGR), from $336.47M to $1.64B.